Abstract
Omacetaxine added to a standard acute myeloid leukaemia chemotherapy regimen reduces cellular FLIP levels, markedly increasing the incidence of eccrine hidradenitis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have